Navigation Links
New conference tackles the tough questions in lung cancer
Date:4/4/2008

Lugano, Switzerland, 4th April 2008 Experts from around the world are gathering in Geneva next month at a new conference that aims to improve lung cancer treatment and answer unsolved questions about a disease that kills 1.5 million people each year.

The First European Lung Cancer Conference is an initiative of the International Association for the Study of Lung Cancer (IASLC) and the European Society for Medical Oncology (ESMO). It will be held from 23 to 26 April.

"The main objective of this meeting is to advance the quality of lung cancer treatment and find answers to unsolved problems which can contribute substantially to the improvement of patient survival," said Prof. Franoise Mornex, France, Scientific Co-Chair of the conference.

The meeting will include new scientific and clinical results from presented abstracts, as well as invited plenary speeches from top international experts.

Prof. Joseph Nevins from the Duke University Medical Center, US and Prof. David Beer from the University of Michigan, US will present new data showing how genetic signatures in early lung cancer can help doctors tailor treatments more effectively.

"The current methods for staging early lung cancer have limited success in predicting which patients will be cured and which will have cancer recurrence," says Prof. Rafael Rosell, Spain, the other Scientific Co-Chair of the conference. "This is a good example of one of the unsolved problems in lung cancer treatment we hope to address at this meeting."

Two significant controversy sessions will address new concepts in the treatment of both early and advanced lung cancer, announces Prof. Mornex: the use of alternative efficient treatments such as radiofrequency and radiation versus surgery in early lung cancer, and the role of surgery as a standard treatment for stage III non-small-cell lung cancer.

Other highlights of the conference will include a report about a new, highly accurate diagnostic test for lung squamous cell carcinoma, studies probing the role human viruses play in lung cancers, positive results from a trial of immunotherapy to treat lung cancer, and efficacy and safety results from an interim analysis of a phase III trial on stage IIIB-IV nonsmall-cell lung cancer.

"The conference will also feature workshops on molecular biology and targeted therapies that embody part of the future of lung cancer treatment," said Prof. Rosell.

"We hope that the work presented at the conference in these areas will contribute to great advances for many lung cancer patients."


'/>"/>

Contact: Vanessa Pavinato
media@esmo.org
41-919-731-907
European Society for Medical Oncology
Source:Eurekalert

Related medicine news :

1. SXC Health Solutions to Present at the Suntrust 37th Annual Institutional Conference
2. Covance Inc. Invites You to Join the Webcast of Its First Quarter 2008 Financial Results Conference Call
3. Ventas to Present at Credit Suisse 2008 Global Real Estate Conference
4. Lilly Adjusts Time of Conference Call for First Quarter 2008 Financial Results Announcement
5. Hospice Community to Focus on Advocacy at National Leadership Conference
6. Zimmer Holdings Announces Live Audio Webcast and Conference Call of First Quarter 2008 Results
7. Running Pioneer Kathrine Switzer Will Headline Women on the Move Conference August 13-15, 2008 in Spearfish, SD
8. Shannon Brownlee, Author of Overtreated, to Keynote at Defined Healths 8th Annual Therapeutic Insight Conference
9. Abbott Hosts Conference Call for First-Quarter Earnings
10. Latest Advances in Diabetes Research to be Presented in San Francisco, California at Worlds Largest Diabetes Conference, June 6-10, 2008
11. USAID Participates in White House Office of Faith-Based and Community Initiatives Conferences in Rwanda and Zambia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2017)... ... 2017 , ... KICKICO , a protocol built on Ethereum for more ... catastrophic issues within funding campaigns. KICKICO developers are testing the platform, which will launch ... raising of funds through the power of many - has been around for about ...
(Date:6/25/2017)... ... ... lyric music video in Final Cut Pro X with ProLyric from Pixel Film Studios. Users ... to any song. ProLyric flies in the text for each section and it hovers around ... for optimal control. ProLyric makes editing any music video or text-based production easier than ever. ...
(Date:6/25/2017)... , ... June 25, 2017 , ... CareSet Labs released ... in New Orleans. This is a new, greatly improved version of the Doctor Referral ... (FOIA) requests by Fred Trotter and subsequently called the the “Doctor Referral Dataset” as ...
(Date:6/24/2017)... ... June 24, 2017 , ... ... testing for medications in select Florida and Texas doctors' offices and clinics. This ... new application of genetic testing recognizes the role genes play in determining an ...
(Date:6/24/2017)... , ... June 24, 2017 , ... The weather is ... time outdoors. Home and business owners should be aware that the summer months provide ... In fact, mechanical locks and keys can be negatively affected from direct exposure to ...
Breaking Medicine News(10 mins):
(Date:5/24/2017)... Va. , May 24, 2017  ivWatch ... Original Equipment Manufacturer (OEM) Board to enable seamless ... with patient monitoring systems, infusion pumps and other ... OEMs will be able to help health care ... and reduced risks related to IV therapy. ...
(Date:5/22/2017)... Fla. , May 22, 2017  As ... as a whole continue to make the revolutionary ... becomes increasingly important for ensuring positive patient outcomes ... industry stakeholders are shifting focus away from clinical ... and effects of long-term specialty drug therapy utilization ...
(Date:5/15/2017)... -- Amy Baxter MD, chief executive officer and founder of ... was awarded a 2017 Top 40 Healthcare Transformer designation ... the MM&M Top 40 Healthcare Transformers dinner and awards ... May 10, 2017. The dinner followed a full-day conference ... pill."  "Innovation goes beyond invention," noted Baxter ...
Breaking Medicine Technology: